News and media menu
Published date
- October 2025 (2)
- September 2025 (1)
- July 2025 (1)
- June 2025 (2)
- May 2025 (1)
- March 2025 (1)
- December 2024 (2)
- November 2024 (1)
- September 2024 (1)
- August 2024 (1)
- July 2024 (1)
- May 2024 (1)
- March 2024 (1)
- February 2024 (1)
- January 2024 (1)
- December 2023 (3)
- November 2023 (2)
- September 2023 (2)
- August 2023 (2)
- July 2023 (1)
- June 2023 (1)
- March 2023 (2)
- December 2022 (3)
- November 2022 (1)
- July 2022 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- April 2021 (1)
- February 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (2)
- September 2020 (1)
- July 2020 (1)
- June 2020 (1)
- May 2020 (1)
- January 2020 (3)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- June 2019 (2)
- April 2019 (1)
- March 2019 (1)
- December 2018 (2)
- October 2018 (1)
- July 2018 (1)
- May 2018 (1)
- March 2018 (1)
- January 2018 (2)
- October 2017 (1)
- August 2017 (2)
- June 2017 (5)
- May 2017 (2)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- December 2016 (1)
- October 2016 (2)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
Search
88 result(s) found, displaying 1 to 25
- The Medicinal Cannabis Expert Working Group (MCEWG) met for its sixth meeting on Tuesday 19 August 2025. .
- The 2024 data on cannabis-related activities regulated by the Office of Drug Control is now available.
- We have given two infringement notices totalling $39,600 to Tasmanian-based company Tasmanian Botanics Pty Ltd (Tasmanian Botanics) for alleged breaches of its medicinal cannabis licence.
- We have issued an infringement notice totalling $19,800 to Queensland-based company Cannatrek Technologies Pty Ltd (Cannatrek) for alleged breaches of its medicinal cannabis licence.
- The Medicinal Cannabis Expert Working Group (MCEWG) met for its fifth meeting on Wednesday 21 May 2025.
- We have begun issuing a periodic newsletter designed to keep you informed about the latest developments, key topics, and important issues related to our work and engagement with the industry.
- The Medicinal Cannabis Expert Working Group (MCEWG) met for its fourth meeting in Canberra on Tuesday 25 February 2025
- From 1 March 2025, new substances included under Schedule 4 of the Customs (Prohibited Imports) Regulations 1956 will require a licence and permit for import and/or export issued by us.
- The Medicinal Cannabis Expert Working Group (MCEWG) met for its third meeting in Melbourne on Wednesday 16 October 2024.
- We will be progressively adding more digital forms and enhanced functionality, enabling you to complete a range of tasks online.
- The HBS Portal is open for new medicinal cannabis and narcotic drug manufacture licence applications to the Office of Drug Control.
- The Medicinal Cannabis Expert Working Group (MCEWG) met for its second meeting in Canberra on Wednesday 17 July 2024
- The 2023 data on cannabis-related activities regulated by the Office of Drug Control is now available.
- The Medicinal Cannabis Expert Working Group (MCEWG) met for its first meeting in Melbourne on Wednesday 17 April 2024
- We are transitioning to an online system for submitting new licence applications from mid-2024. The changes will affect how you will submit a new licence application.
- This year we will be establishing an online portal, making it easier and more convenient for you to do business with us.
- Find out about new substances requiring a licence and permit for import and/or export issued by us, the Office of Drug Control (ODC), From 21 February 2024.
- New import controls have been introduced for vaping goods under the Customs (Prohibited Imports) Regulations 1956.
- The Kava pilot ends on 31 December 2023. The Australian Government will make a decision on future imports of kava. Until then, importers can continue to apply for import permission for kava. Read the final report.
- From 13 December 2023 there are new substances requiring a licence and permit for import and export.
- Find out information about the quantity of cannabis imported, exported, produced, and held in stock.
- The changes will help address the significant public health issues caused by vaping in Australia, while keeping legitimate patient access to therapeutic vapes.
- We have issued six infringement notices totalling $99,000 to Queensland-based company Cannatrek Technologies Pty Ltd (Cannatrek) for alleged breaches of its medicinal cannabis licence.
- The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #21.
- The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #22.